该产品被引用文献
PubMed=4094096; DOI=10.1093/oxfordjournals.jjco.a039097Lee Y.-C., Saijo N., Sasaki Y., Takahashi H., Sakurai M., Ishihara J., Hoshi A., Chen K.-M., Hamburger A.W.Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.Jpn. J. Clin. Oncol. 15:637-644(1985)PubMed=1847845; DOI=10.1007/BF00685110Sasaki Y., Shinkai T., Eguchi K., Tamura T., Ohe Y., Ohmori T., Saijo N.Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.Cancer Chemother. Pharmacol. 27:263-270(1991)PubMed=10358721; DOI=10.18926/AMO/31626Matsushita A., Tabata M., Ueoka H., Kiura K., Shibayama T., Aoe K., Kohara H., Harada M.Establishment of a drug sensitivity panel using human lung cancer cell lines.Acta Med. Okayama 53:67-75(1999)PubMed=11005564; DOI=10.1038/sj.neo.7900094Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J.Mutation and expression of the DCC gene in human lung cancer.Neoplasia 2:300-305(2000)PubMed=14581340Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J.TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.Clin. Cancer Res. 9:4705-4713(2003)PubMed=15185009; DOI=10.1007/s00262-004-0533-9Yamaji H., Iizasa T., Koh E., Suzuki M., Otsuji M., Chang H., Motohashi S., Yokoi S., Hiroshima K., Tagawa M., Nakayama T., Fujisawa T.Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.Cancer Immunol. Immunother. 53:786-792(2004)PubMed=15746151; DOI=10.1093/hmg/ddi092Izumi H., Inoue J., Yokoi S., Hosoda H., Shibata T., Sunamori M., Hirohashi S., Inazawa J., Imoto I.Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers.Hum. Mol. Genet. 14:997-1007(2005)PubMed=15901131; DOI=10.1016/j.prp.2005.01.002Murai Y., Hayashi S., Takahashi H., Tsuneyama K., Takano Y.Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines.Pathol. Res. Pract. 201:109-115(2005)PubMed=16105816; DOI=10.1158/0008-5472.CAN-05-0331Nagai Y., Miyazawa H., Huqun X., Tanaka T., Udagawa K., Kato M., Fukuyama S., Yokote A., Kobayashi K., Kanazawa M., Hagiwara K.Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.Cancer Res. 65:7276-7282(2005)PubMed=19472407; DOI=10.1002/humu.21028Blanco R., Iwakawa R., Tang M., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.A gene-alteration profile of human lung cancer cell lines.Hum. Mutat. 30:1199-1206(2009)PubMed=20164919; DOI=10.1038/nature08768Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F., Campbell P.J., Futreal P.A., Stratton M.R.Signatures of mutation and selection in the cancer genome.Nature 463:893-898(2010)PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.Cancer Res. 70:2158-2164(2010)PubMed=22313637; DOI=10.4161/cbt.19238Takata M., Chikumi H., Miyake N., Adachi K., Kanamori Y., Yamasaki A., Igishi T., Burioka N., Nanba E., Shimizu E.Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.Cancer Biol. Ther. 13:369-378(2012)PubMed=22460905; DOI=10.1038/nature11003Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature 483:603-607(2012)PubMed=25120651; DOI=10.3892/ol.2014.2234Suzuki M., Ikeda K., Shiraishi K., Eguchi A., Mori T., Yoshimoto K., Shibata H., Ito T., Baba Y., Baba H.Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer.Oncol. Lett. 8:1025-1030(2014)PubMed=27397505; DOI=10.1016/j.cell.2016.06.017Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.A landscape of pharmacogenomic interactions in cancer.Cell 166:740-754(2016)PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.Cancer Res. 79:1263-1273(2019)PubMed=31068700; DOI=10.1038/s41586-019-1186-3Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature 569:503-508(2019)PubMed=31978347; DOI=10.1016/j.cell.2019.12.023Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E., Schweppe D.K., Jedrychowski M., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.Quantitative proteomics of the Cancer Cell Line Encyclopedia.Cell 180:387-402.e16(2020)